Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-09

Clinical Trial Update: Safety and Efficacy of SH T00660AA in Treatment of Endometriosis [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluating the safety and efficacy of SH T00660AA for endometriosis, sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SH T00660AA

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 3 | Status: COMPLETED